The big drugmaker faces some challenges. Its COVID-19 vaccine sales have declined sharply, and several of Pfizer's top-selling products will lose patent exclusivity over the next few years. However, Pfizer has invested heavily in research and development (R&D).
The company has also made several key acquisitions, including the purchase of Seagen in 2023. These moves have put Pfizer in a solid position to deliver long-term growth.
The drugmaker's pipeline includes more than 100 candidates. Roughly one-third of these programs are either in late-stage testing or awaiting approval. The company also has promising drugs in earlier-stage development.
Pfizer has long been a favorite among income-seeking investors. Its forward dividend yield is among the highest in the pharmaceutical industry.
How to invest in pharmaceutical companies
The basics of investing in pharmaceutical companies are no different than investing in any stock. Follow these steps to invest in pharma stocks:
- Open your brokerage app: Log in to your brokerage account where you handle your investments.
- Search for the stock: Enter the ticker or company name into the search bar to bring up the stock's trading page.
- Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
- Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
- Submit your order: Confirm the details and submit your buy order.
- Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.
Choosing the best pharmaceutical stocks
Knowing what to look for can help you identify the best pharmaceutical stocks. The top pharma companies have a few key characteristics in common, including:
- They usually increase their revenue and earnings consistently.
- They have robust pipelines that allow them to offset any revenue declines resulting from patent expirations.
- They are adept at developing new therapies and using existing drugs for new purposes.
- They make smart business development deals that bolster their internal research and development.